Thorium-232

Jump to: navigation, search

WikiDoc Resources for Thorium-232

Articles

Most recent articles on Thorium-232

Most cited articles on Thorium-232

Review articles on Thorium-232

Articles on Thorium-232 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Thorium-232

Images of Thorium-232

Photos of Thorium-232

Podcasts & MP3s on Thorium-232

Videos on Thorium-232

Evidence Based Medicine

Cochrane Collaboration on Thorium-232

Bandolier on Thorium-232

TRIP on Thorium-232

Clinical Trials

Ongoing Trials on Thorium-232 at Clinical Trials.gov

Trial results on Thorium-232

Clinical Trials on Thorium-232 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Thorium-232

NICE Guidance on Thorium-232

NHS PRODIGY Guidance

FDA on Thorium-232

CDC on Thorium-232

Books

Books on Thorium-232

News

Thorium-232 in the news

Be alerted to news on Thorium-232

News trends on Thorium-232

Commentary

Blogs on Thorium-232

Definitions

Definitions of Thorium-232

Patient Resources / Community

Patient resources on Thorium-232

Discussion groups on Thorium-232

Patient Handouts on Thorium-232

Directions to Hospitals Treating Thorium-232

Risk calculators and risk factors for Thorium-232

Healthcare Provider Resources

Symptoms of Thorium-232

Causes & Risk Factors for Thorium-232

Diagnostic studies for Thorium-232

Treatment of Thorium-232

Continuing Medical Education (CME)

CME Programs on Thorium-232

International

Thorium-232 en Espanol

Thorium-232 en Francais

Business

Thorium-232 in the Marketplace

Patents on Thorium-232

Experimental / Informatics

List of terms related to Thorium-232


Overview

Thorium-232 is the primary abundant nuclide of thorium. It is a slightly unstable radionuclide that is found in the earth's crust. It is a fertile material able to absorb a neutron and undergo transmutation into a nuclide that is able to support fission (uranium-233).

In the form of Thorotrast, a thorium oxide suspension, it was used as contrast medium in early X-ray diagnostics. Thorium-232 is now classified as carcinogenic. The half-life of thorium-232 is 1.405×1010 years.



Linked-in.jpg